These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 11406166)

  • 1. Recognition of cisplatin adducts by cellular proteins.
    Kartalou M; Essigmann JM
    Mutat Res; 2001 Jul; 478(1-2):1-21. PubMed ID: 11406166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition and repair of DNA-cisplatin adducts.
    Woźniak K; Błasiak J
    Acta Biochim Pol; 2002; 49(3):583-96. PubMed ID: 12422229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin.
    Trimmer EE; Essigmann JM
    Essays Biochem; 1999; 34():191-211. PubMed ID: 10730196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins.
    Ohndorf UM; Rould MA; He Q; Pabo CO; Lippard SJ
    Nature; 1999 Jun; 399(6737):708-12. PubMed ID: 10385126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin-DNA adducts inhibit translocation of the Ku subunits of DNA-PK.
    Turchi JJ; Henkels KM; Zhou Y
    Nucleic Acids Res; 2000 Dec; 28(23):4634-41. PubMed ID: 11095672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repair of cisplatin--DNA adducts by the mammalian excision nuclease.
    Zamble DB; Mu D; Reardon JT; Sancar A; Lippard SJ
    Biochemistry; 1996 Aug; 35(31):10004-13. PubMed ID: 8756462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin.
    Takahara PM; Rosenzweig AC; Frederick CA; Lippard SJ
    Nature; 1995 Oct; 377(6550):649-52. PubMed ID: 7566180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
    Kasparkova J; Novakova O; Farrell N; Brabec V
    Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermodynamic properties of duplex DNA containing a site-specific d(GpG) intrastrand crosslink formed by an antitumor dinuclear platinum complex.
    Hofr C; Farrell N; Brabec V
    Nucleic Acids Res; 2001 May; 29(10):2034-40. PubMed ID: 11353072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replacement of an NH(3) by an iminoether in transplatin makes an antitumor drug from an inactive compound.
    Leng M; Locker D; Giraud-Panis MJ; Schwartz A; Intini FP; Natile G; Pisano C; Boccarelli A; Giordano D; Coluccia M
    Mol Pharmacol; 2000 Dec; 58(6):1525-35. PubMed ID: 11093793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of DNA interstrand cross-links of cis-diamminedichloroplatinum(II) and its trans isomer by DNA-binding proteins.
    Kaspárková J; Brabec V
    Biochemistry; 1995 Sep; 34(38):12379-87. PubMed ID: 7547982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin adducts inhibit 1,N(6)-ethenoadenine repair by interacting with the human 3-methyladenine DNA glycosylase.
    Kartalou M; Samson LD; Essigmann JM
    Biochemistry; 2000 Jul; 39(27):8032-8. PubMed ID: 10891085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition of platinum-DNA damage by poly(ADP-ribose) polymerase-1.
    Zhu G; Chang P; Lippard SJ
    Biochemistry; 2010 Jul; 49(29):6177-83. PubMed ID: 20550106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of tsHMG, a mouse testis-specific HMG-domain protein, to cisplatin-DNA adducts.
    Ohndorf UM; Whitehead JP; Raju NL; Lippard SJ
    Biochemistry; 1997 Dec; 36(48):14807-15. PubMed ID: 9398202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformation, protein recognition and repair of DNA interstrand and intrastrand cross-links of antitumor trans-[PtCl2(NH3)(thiazole)].
    Marini V; Christofis P; Novakova O; Kasparkova J; Farrell N; Brabec V
    Nucleic Acids Res; 2005; 33(18):5819-28. PubMed ID: 16237123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin.
    Mello JA; Acharya S; Fishel R; Essigmann JM
    Chem Biol; 1996 Jul; 3(7):579-89. PubMed ID: 8807890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential recognition by the tumor suppressor protein p53 of DNA modified by the novel antitumor trinuclear platinum drug BBR3464 and cisplatin.
    Kasparkova J; Fojta M; Farrell N; Brabec V
    Nucleic Acids Res; 2004; 32(18):5546-52. PubMed ID: 15486204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of resistance to cisplatin.
    Kartalou M; Essigmann JM
    Mutat Res; 2001 Jul; 478(1-2):23-43. PubMed ID: 11406167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass spectrometry of cis-diamminedichloroplatinum(II) adducts with the dinucleosidemonophosphates d(ApG), d(GpG) and d(TpC) in an ion trap.
    Hagemeister T; Linscheid M
    J Mass Spectrom; 2002 Jul; 37(7):731-47. PubMed ID: 12125006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monofunctional platinum-DNA adducts are strong inhibitors of transcription and substrates for nucleotide excision repair in live mammalian cells.
    Zhu G; Myint M; Ang WH; Song L; Lippard SJ
    Cancer Res; 2012 Feb; 72(3):790-800. PubMed ID: 22180496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.